SDZXF:OTCMKTS
Sandoz Group AG
89,26Â US$
0,00%
(0,00) 1K
25-avg, 14:21:02 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoSDZXF tikeri uchun statistika yaratilmoqda...
Bozor kapitali
30,59Â mlrd
Oʻrtacha hajm
1,01Â ming
Hajmi
0,00
52 haftalik eng yuqori
94,55Â US$
52 haftalik eng past
55,50Â US$
Muomaladagi aksiyalar
440,00Â mln
Xodimlar soni
20Â ming
Bozor kapitali
30,59Â mlrd
Oʻrtacha hajm
1,01Â ming
Hajmi
0,00
52 haftalik eng yuqori
94,55Â US$
52 haftalik eng past
55,50Â US$
Muomaladagi aksiyalar
440,00Â mln
Xodimlar soni
20Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Business Post Nigeria
·
7 soat oldin
Alpro Pharmacy, Sandoz Malaysia and Doc2Us Launch ACCESS360 to Make Stroke
Profil
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Sandoz Group AG haqida